47 related articles for article (PubMed ID: 19766178)
1. Poly(allylamine)-tripolyphosphate Ionic Assemblies as Nanocarriers: Friend or Foe?
Apuzzo E; Agazzi M; Herrera SE; Picco A; Rizzo G; Chavero C; Bianchi D; Smaldini P; Cortez ML; Marmisollé WA; Padula G; Seoane A; Alomar ML; Denofrio MP; Docena G; Azzaroni O
ACS Appl Bio Mater; 2023 Nov; 6(11):4714-4727. PubMed ID: 37863908
[TBL] [Abstract][Full Text] [Related]
2. Polymer nanoassemblies with solvato- and halo-fluorochromism for drug release monitoring and metastasis imaging.
Reichel D; Rychahou P; Bae Y
Ther Deliv; 2015; 6(10):1221-37. PubMed ID: 26446432
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
4. Polyallylamine Binds to Aβ Amyloid and Inhibits Antibody Recognition.
Tsuchie Y; Kusuda S; Kawabe H; Mori W; Lindgren M; Watanabe Y; Zako T
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542086
[TBL] [Abstract][Full Text] [Related]
5. Peptide Antibiotic-Polyphosphate Nanoparticles: A Promising Strategy to Overcome the Enzymatic and Mucus Barrier of the Intestine.
Saleh A; Akkuş-Dağdeviren ZB; Haddadzadegan S; Wibel R; Bernkop-Schnürch A
Biomacromolecules; 2023 Jun; 24(6):2587-2595. PubMed ID: 37224061
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle Delivery Systems in the Treatment of Diabetes Complications.
Souto EB; Souto SB; Campos JR; Severino P; Pashirova TN; Zakharova LY; Silva AM; Durazzo A; Lucarini M; Izzo AA; Santini A
Molecules; 2019 Nov; 24(23):. PubMed ID: 31756981
[TBL] [Abstract][Full Text] [Related]
7. Functionalized Polymers for Enhance Oral Bioavailability of Sensitive Molecules.
Pérez YA; Urista CM; Martínez JI; Nava MDCD; Rodríguez FAR
Polymers (Basel); 2016 Jun; 8(6):. PubMed ID: 30979310
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days.
Navarro SM; Darensbourg C; Cross L; Stout R; Coulon D; Astete CE; Morgan T; Sabliov CM
Ther Deliv; 2014 Nov; 5(11):1191-201. PubMed ID: 25491670
[TBL] [Abstract][Full Text] [Related]
9. Uptake and transport of novel amphiphilic polyelectrolyte-insulin nanocomplexes by Caco-2 cells--towards oral insulin.
Thompson C; Cheng WP; Gadad P; Skene K; Smith M; Smith G; McKinnon A; Knott R
Pharm Res; 2011 Apr; 28(4):886-96. PubMed ID: 21213024
[TBL] [Abstract][Full Text] [Related]
10. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
[TBL] [Abstract][Full Text] [Related]
11. Challenges and advances in nanoparticle-based oral insulin delivery.
Ramesan RM; Sharma CP
Expert Rev Med Devices; 2009 Nov; 6(6):665-76. PubMed ID: 19911877
[TBL] [Abstract][Full Text] [Related]
12. The influence of polymer architecture on the protective effect of novel comb shaped amphiphilic poly(allylamine) against in vitro enzymatic degradation of insulin--towards oral insulin delivery.
Thompson CJ; Tetley L; Cheng WP
Int J Pharm; 2010 Jan; 383(1-2):216-27. PubMed ID: 19766178
[TBL] [Abstract][Full Text] [Related]
13. The complexation between novel comb shaped amphiphilic polyallylamine and insulin: towards oral insulin delivery.
Thompson CJ; Tetley L; Uchegbu IF; Cheng WP
Int J Pharm; 2009 Jul; 376(1-2):46-55. PubMed ID: 19375489
[TBL] [Abstract][Full Text] [Related]
14. Self-assembling nanocomplexes from insulin and water-soluble branched polyesters, poly[(vinyl-3-(diethylamino)- propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft- poly(L-lactic acid): a novel carrier for transmucosal delivery of peptides.
Simon M; Wittmar M; Bakowsky U; Kissel T
Bioconjug Chem; 2004; 15(4):841-9. PubMed ID: 15264872
[TBL] [Abstract][Full Text] [Related]
15. Complexation of novel thiomers and insulin to protect against in vitro enzymatic degradation - towards oral insulin delivery.
Ibie CO; Knott RM; Thompson CJ
Drug Dev Ind Pharm; 2019 Jan; 45(1):67-75. PubMed ID: 30252537
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
